DATA GUIDANCE TABLES The four data guidance tables propose a range of options for jurisdictions to consider for data collection. Many more options are proposed than are likely to be relevant or possible. The data guidance tables list indicators that are high-level and not cancer type specific, so that they can be applied across all 15 Optimal Cancer Care Pathways. Some jurisdictions with the data capabilities may choose to collect and report on cancer type–specific data at much greater depth than suggested in this guidance Table .Monitoring Policy and Strategy Alignment (question 1) Aspect of Possible high-level indicators Data source options to consider embedding Optimal Cancer Care Pathways Percentage of cancer services that Jurisdictional-led survey Awareness of are actively communicating Optimal Communications activity data as a information about Optimal Cancer proxy for message reach Cancer Care Pathways to their staff Care Percentage of cancer health Pathways professionals who are trial of across Optimal Cancer Care Pathways cancer services and among health and other staff Number of Memoranda of Jurisdictional records Formal Understanding (MOU) or other agreements formal agreements to adopt to adopt Optimal Cancer Care Pathways Optimal Cancer Care Pathways Number of clinical pathways with Analysis of cancer plans and clinical Incorporation of explicit reference to Optimal pathways Optimal Cancer Care Pathways Jurisdictional-led survey Cancer Number of clinical pathways (acknowledge that this will be Care reviewed in line with Optimal influenced by planning cycles and Pathways in Cancer Care Pathways timeframes for jurisdictions’ Cancer planning for Control Plans) jurisdictional Explicit reference to Optimal Cancer Care Pathways within cancer jurisdictional and local service plans and policies clinical pathways Explicit reference to Optimal Cancer Care Pathways within
DATA GUIDANCE TABLES The four data guidance tables propose a range of options for jurisdictions to consider for data collection. Many more options are proposed than are likely to be relevant or possible. The data guidance tables list indicators that are high-level and not cancer type specific, so that they can be applied across all 15 Optimal Cancer Care Pathways. Some jurisdictions with the data capabilities may choose to collect and report on cancer type–specific data at much greater depth than suggested in this guidance Table .Monitoring Policy and Strategy Alignment (question 1) Aspect of embedding Optimal Cancer Care Pathways Possible high-level indicators Data source options to consider Awareness of Optimal Cancer Care Pathways across cancer services and among health and other staff Percentage of cancer services that are actively communicating information about Optimal Cancer Care Pathways to their staff Percentage of cancer health professionals who are of Optimal Cancer Care Pathways Jurisdictional-led survey Communications activity data as a proxy for message reach Formal agreements to adopt Optimal Cancer Care Pathways Number of Memoranda of Understanding (MOU) or other formal agreements to adopt Optimal Cancer Care Pathways Jurisdictional records Incorporation of Optimal Cancer Care Pathways in planning for jurisdictional cancer plans and clinical pathways Number of clinical pathways with explicit reference to Optimal Cancer Care Pathways Number of clinical pathways reviewed in line with Optimal Cancer Care Pathways Explicit reference to Optimal Cancer Care Pathways within jurisdictional and local service policies Explicit reference to Optimal Cancer Care Pathways within Analysis of cancer plans and clinical pathways Jurisdictional-led survey (acknowledge that this will be influenced by planning cycles and timeframes for jurisdictions’ Cancer Control Plans) trial
Data%20Guidance%20Tables.docx